Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
D. Arik, C. Tasci, M. Ozkan, H. Bilgic, C. Acikel, I. Kurt (Ankara, Turkey). The value of exhaled breath condensate ‘pH‘ to evaluate the severity of disease and the response to treatment in patients with community acquired pneumonia. Eur Respir J 2011; 38: Suppl. 55, 2490

Member's Comments

No comment yet.

Related content which might interest you: pH in exhaled breath condensate of patients with stable COPD: associations with disease severity and pulmonary function tests Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009 The clinical significance of growth factors measurement in exhaled breath condensates (EBC) among patients with interstitial lung diseases Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010 Exhaled breath condensate biomarkers in COPD Source: Eur Respir J 2008; 32: 472-486 Year: 2008 Exhaled breath condensate (EBC): what is sampled and how should it be collected? (recommendations and open issues) Source: Annual Congress 2007 - ERS/ATS joint symposium: the report of the ERS/ATS Task Force on Exhaled Breath Condensate Year: 2007 The impact of acute smoke exposure on selected biomarkers in exhaled breath condensate in COPD patients and healthy smokers Source: International Congress 2016 – Molecular pathways of smoking-induced diseases Year: 2016 Analysis of exhaled breath and its value in prediction of exacerbations in children suffering from CF Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease Year: 2009 Assessment of exhaled breath condensate pH in asthma and COPD patients with exacerbation Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010 When will exhaled biomarkers influence diagnosis and follow-up of patients with respiratory disease? Source: International Congress 2015 – The next generation of lung function tests Year: 2015 Early detection of patients with asthma or chronic bronchitis by investigation on exhaled air condensate Source: Eur Respir J 2002; 20: Suppl. 38, 275s Year: 2002 Decreased levels of bis-S-bimane in exhaled breath condensate of COPD Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015 Markers of airway diseases in exhaled breath condensate and their clinical value Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases Year: 2013 Addition of exhaled breath condensate pH toPEF monitoring to improve the diagnosis of occupational asthma Source: Annual Congress 2010 - Occupational asthma Year: 2010 Exhaled breath condensate for evaluation of inflammation in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 35s Year: 2006 Prediction of asthma exacerbations in children by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008 Differential diagnosis between newly diagnosed asthma and COPD using exhaled breath condensate metabolomics: a pilot study Source: Eur Respir J, 51 (3) 1701825; 10.1183/13993003.01825-2017 Year: 2018 The role of galactomannan in exhaled breath condensate in detecting pulmonary aspergillosis in patients with exacerbated COPD Source: Annual Congress 2012 - Prognostic indices in respiratory infections Year: 2012 Relationship between sputum analysis, methacholine challenge testing and exhaled breath condensate pH in patients with mild-to-moderate well-controlled asthma Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010 Oxidative stress in expired breath condensate of patients with COPD: relationships with airway inflammation, and disease severity Source: Eur Respir J 2002; 20: Suppl. 38, 284s Year: 2002 Lactate, pH and angiogenetic markers in exhaled breath condensate correlate with outcome and disease severity in patients with acute lung injury Source: Annual Congress 2011 - Mechanisms of acute lung injury and mesenchymal cell treatment Year: 2011 Ability of an individual device for measurement of the temperature of exhaled breath to detect changes in patients recovering from mild exacerbations of asthma Source: Annual Congress 2008 - Inflammatory biomarkers Year: 2008